LLY

934.48

-5.5%↓

JNJ

240.19

-0.84%↓

ABBV

221.83

-0.07%↓

NVS

154.93

+0.32%↑

AZN

191.77

+0.14%↑

LLY

934.48

-5.5%↓

JNJ

240.19

-0.84%↓

ABBV

221.83

-0.07%↓

NVS

154.93

+0.32%↑

AZN

191.77

+0.14%↑

LLY

934.48

-5.5%↓

JNJ

240.19

-0.84%↓

ABBV

221.83

-0.07%↓

NVS

154.93

+0.32%↑

AZN

191.77

+0.14%↑

LLY

934.48

-5.5%↓

JNJ

240.19

-0.84%↓

ABBV

221.83

-0.07%↓

NVS

154.93

+0.32%↑

AZN

191.77

+0.14%↑

LLY

934.48

-5.5%↓

JNJ

240.19

-0.84%↓

ABBV

221.83

-0.07%↓

NVS

154.93

+0.32%↑

AZN

191.77

+0.14%↑

Search

Twist Bioscience Corp

Ouvert

SecteurSoins de santé

46.96 4.05

Résumé

Variation du prix de l'action

24h

Actuel

Min

44.65

Max

46.98

Chiffres clés

By Trading Economics

Revenu

-3.4M

-31M

Ventes

4.7M

104M

Marge bénéficiaire

-29.419

Employés

979

EBITDA

-3.2M

-24M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+20.15% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

362M

3B

Ouverture précédente

42.91

Clôture précédente

46.96

Sentiment de l'Actualité

By Acuity

50%

50%

150 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Twist Bioscience Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

16 mars 2026, 21:37 UTC

Acquisitions, Fusions, Rachats

Lensar and Alcon Agree to Terminate Merger

16 mars 2026, 19:06 UTC

Principaux Événements d'Actualité

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

16 mars 2026, 17:44 UTC

Acquisitions, Fusions, Rachats

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

16 mars 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 mars 2026, 23:46 UTC

Market Talk

Nikkei May Rise After Oil Prices Decline -- Market Talk

16 mars 2026, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

16 mars 2026, 23:05 UTC

Market Talk

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

16 mars 2026, 21:56 UTC

Market Talk

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

16 mars 2026, 21:41 UTC

Market Talk
Principaux Événements d'Actualité

Global Equities Roundup: Market Talk

16 mars 2026, 21:41 UTC

Market Talk
Principaux Événements d'Actualité

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mars 2026, 20:57 UTC

Acquisitions, Fusions, Rachats

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

16 mars 2026, 20:51 UTC

Acquisitions, Fusions, Rachats

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

16 mars 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Energy & Utilities Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

16 mars 2026, 19:53 UTC

Principaux Événements d'Actualité

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

16 mars 2026, 19:43 UTC

Market Talk

Global Equities Roundup: Market Talk

16 mars 2026, 19:43 UTC

Market Talk

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

16 mars 2026, 19:37 UTC

Market Talk
Principaux Événements d'Actualité

Natural Gas Follows Oil Prices Lower -- Market Talk

16 mars 2026, 19:20 UTC

Principaux Événements d'Actualité

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

16 mars 2026, 19:17 UTC

Market Talk
Principaux Événements d'Actualité

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

16 mars 2026, 19:00 UTC

Market Talk

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

16 mars 2026, 18:23 UTC

Market Talk

LME Restarts Trading After Outage -- Market Talk

16 mars 2026, 17:36 UTC

Principaux Événements d'Actualité

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

16 mars 2026, 17:19 UTC

Market Talk

Grains Sink as Investors Steer Toward Equities -- Market Talk

16 mars 2026, 17:14 UTC

Principaux Événements d'Actualité

Trump Ends News Conference

Comparaison

Variation de prix

Twist Bioscience Corp prévision

Objectif de Prix

By TipRanks

20.15% hausse

Prévisions sur 12 Mois

Moyen 52 USD  20.15%

Haut 58 USD

Bas 50 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

6

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

31.56 / 38.6884Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

150 / 351Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat